Hu Hao
Hu Hao — Chief Physician — Urology — Peking University People's Hospital
Specialties
Minimally invasive treatment of kidney stones and ureteral stones, minimally invasive treatment of hydronephrosis caused by refractory or complex ureteral strictures, minimally invasive treatment of urinary system tumors such as prostate cancer, bladder cancer, kidney cancer, renal pelvis cancer, and ureteral cancer, and minimally invasive treatment of urination dysfunction diseases such as benign prostatic hyperplasia.
Education
Graduated in 2006 from the Clinical Medicine Department (English Program) of China Medical University with a bachelor's degree, and was admitted the same year to Peking University Health Science Center for a master's degree, receiving a Doctor of Medicine degree from Peking University in 2011.
Professional Experience
Associate Director of the Department of Urology at Peking University People's Hospital, Chief Physician, Associate Professor, PhD Supervisor. The main clinical specialty areas are minimally invasive surgical treatment of urinary tract tumors, urinary tract stones, and complex upper urinary tract obstructions. In August 2018, successfully completed China's first implantation of a covered metal ureteral stent. Performs nearly a thousand surgeries annually for urinary tract tumors, urinary tract stones, ureteral reconstruction, and ureteral stent placement.
Professional Roles
Youth Committee Member of the Urology Branch of the Chinese Medical Doctor Association, Member of the Medical Robotics Committee of the Chinese Automation Society, Member of the Youth Committee’s Stone Group of the Urology Branch of the Chinese Medical Association, Member of the Stone Group of the Urology Branch of the Beijing Medical Association, Member of the Youth Committee of the Oncology Branch of the Beijing Medical Association, Youth Member of the Urologic Tumor Professional Committee of the Beijing Anti-Cancer Association, Member of the Basic and Translational Research Group of the Urology Branch of the Beijing Medical Association, Member of the Urology and Male Reproductive System Tumor Professional Committee of the Beijing Chronic Disease Prevention and Health Education Research Association, Member and Secretary of the Urology Group of the Rare Disease Branch of the Beijing Medical Association, Member of the Expert Database for Medical Appraisal of the Chinese Medical Association, and the sole representative for China in the Comprehensive Endourological Management of Urogenital Complication (CEMUC) international collaborative group.